Information till studenter och medarbetare med anledning av covid-19 (Uppdaterad: 1 mars 2021)

English
Umeå universitet
printicon

Birgitta Lindh

Kontakt

E-post
birgitta.lindh@vll.se

Verksam vid

Anknytning
Anknuten som läkare till Institutionen för strålningsvetenskaper Enhet: Onkologi
Plats
27C, Målpunkt QC11, Norrlands universitetssjukhus Umeå universitet, 901 87 Umeå
Maintenance Therapy With Cetuximab Every Second Week in the First-Line Treatment of Metastatic Colorectal Cancer: The NORDIC-7.5 Study by the Nordic Colorectal Cancer Biomodulation Group
Clinical colorectal cancer, Vol. 14, (3) : 170-176
Pfeiffer, Per; Sorbye, Hafdan; Qvortrup, Camilla; et al.
Anal carcinoma - Survival and recurrence in a large cohort of patients treated according to Nordic guidelines
Radiotherapy and Oncology, Vol. 113, (3) : 352-358
Leon, Otilia; Guren, Marianne; Hagberg, Oskar; et al.
Impact of the first tumor response at eight weeks on overall survival in metastatic breast cancer patients treated with first-line combination chemotherapy
Medical Oncology, Humana Press 2013, Vol. 30, (1) : 415-
Suzuki, Chikako; Blomqvist, Lennart; Hatschek, Thomas; et al.
Individually tailored treatment with epirubicin and paclitaxel with or without capecitabine as first-line chemotherapy in metastatic breast cancer: a randomized multicenter trial
Breast Cancer Research and Treatment, New York, USA: Springer 2012, Vol. 131, (3) : 939-947
Hatschek, T; Carlsson, L; Einbeigi, Z; et al.
Visa publikationer i DiVA